Видео ютуба по тегу Marina Garassino

Marina Chiara Garassino on Her #WCLC19 Research
Marina Chiara Garassino on Her #WCLC19 Research
Winship Grand Rounds: October 28, 2020 - Marina Garassino, MD
Winship Grand Rounds: October 28, 2020 - Marina Garassino, MD
Prof. Marina Chiara Garassino on the progress and future of targeted combination therapies in NSCLC
Prof. Marina Chiara Garassino on the progress and future of targeted combination therapies in NSCLC
Dr. Garassino: Navigating a Path to Leadership in Thoracic Oncology Research and Education in Italy
Dr. Garassino: Navigating a Path to Leadership in Thoracic Oncology Research and Education in Italy
Combining checkpoint inhibitors with chemotherapy for NSCLC
Combining checkpoint inhibitors with chemotherapy for NSCLC
Dr. Garassino on the PACIFIC Trial for NSCLC
Dr. Garassino on the PACIFIC Trial for NSCLC
Dr. Garassino Discusses Recent Pivotal Immunotherapy Findings in NSCLC
Dr. Garassino Discusses Recent Pivotal Immunotherapy Findings in NSCLC
Dr. Garassino Discusses PROs With Durvalumab by PD-L1 Expression in Stage III NSCLC
Dr. Garassino Discusses PROs With Durvalumab by PD-L1 Expression in Stage III NSCLC
TKIs to treat EGFRm-positive NSCLC
TKIs to treat EGFRm-positive NSCLC
ATLANTIC: durvalumab in the fight against NSCLC
ATLANTIC: durvalumab in the fight against NSCLC
KEYNOTE-189: chemo plus pembrolizumab for NSCLC
KEYNOTE-189: chemo plus pembrolizumab for NSCLC
Garassino Lung cancer cocktail with science
Garassino Lung cancer cocktail with science
Locally Advanced NSCLC: Operable Setting
Locally Advanced NSCLC: Operable Setting
Dr. Garassino on Immunotherapy in EGFR-Mutated Lung Cancer
Dr. Garassino on Immunotherapy in EGFR-Mutated Lung Cancer
Which NSCLC patients should receive chemotherapy and anti-angiogenics?
Which NSCLC patients should receive chemotherapy and anti-angiogenics?
Novel targets for NSCLC
Novel targets for NSCLC
Treating NSCLC with CNS involvement: TKIs with high penetrance
Treating NSCLC with CNS involvement: TKIs with high penetrance
Dr. Garassino on Increased PFS with Ramucirumab Combo for NSCLC
Dr. Garassino on Increased PFS with Ramucirumab Combo for NSCLC